Pharma, biotech shares soar as Trump win calms pricing talk
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
UBS Cuts Price Target as Centene (CNC) Shares Weaken Following 2016 Presidential Election
November 10, 2016 11:06 AM ESTUBS maintained a Buy rating on Centene (NYSE: CNC), and cut the price target to $73.00 (from $80.00), as shares weaken due to uncertainty following the 2016 election. CNC shares declined more than 19% on Wednesday. Based on previous public comments by Congressional leaders, such as House Speaker Paul Ryan, alternative coverage options need to be... More
Standpoint Research Downgrades Celgene (CELG) to Hold
November 9, 2016 11:34 AM ESTStandpoint Research downgraded Celgene (NASDAQ: CELG) from Buy to Hold.
For an analyst ratings summary and ratings history on Celgene click here. For more ratings news on Celgene click here.
Shares of Celgene closed at $108.45 yesterday.
... More